Abnova Taiwan Equity 2024

Abnova Taiwan Aktienanalyse

What does Abnova Taiwan do?

Abnova Taiwan Corp is a global biotechnology company specializing in the production of antibodies used in the diagnosis and treatment of various diseases. Founded in 2002 in Taipei, the company has been at the forefront of utilizing new technologies to automate and streamline the antibody production process. This has allowed Abnova Taiwan Corp to become one of the largest antibody manufacturers worldwide. The company's business model focuses on increasing the efficiency of biotech productions and improving the quality of biochemical reagents. In addition to antibody production, the company also develops and produces recombinant proteins and targeted therapeutics. Abnova Taiwan Corp offers a wide range of in-vitro diagnostic products and is actively involved in cancer research. The company distributes its antibodies and proteins globally through partnerships with distributors and agents. Overall, Abnova Taiwan Corp is a leading biotech company that continually strives to maintain excellence in product quality and efficiency through technological innovation. Abnova Taiwan ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Abnova Taiwan's Equity

Abnova Taiwan's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Abnova Taiwan's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Abnova Taiwan's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Abnova Taiwan's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Abnova Taiwan’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Abnova Taiwan stock

What is the equity of Abnova Taiwan this year?

Abnova Taiwan has equity of 1.29 B TWD this year.

What was the equity of Abnova Taiwan compared to the previous year?

The equity of Abnova Taiwan has increased/decreased by -0.44% decreased compared to the previous year.

What impact does a high equity have on investors of Abnova Taiwan?

A high equity is advantageous for investors of Abnova Taiwan as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Abnova Taiwan?

A low equity can be a risk for investors of Abnova Taiwan, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Abnova Taiwan affect the company?

An increase in equity of Abnova Taiwan can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Abnova Taiwan affect the company?

A reduction in equity of Abnova Taiwan can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Abnova Taiwan?

Some factors that can affect the equity of Abnova Taiwan include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Abnova Taiwan so important for investors?

The equity of Abnova Taiwan is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Abnova Taiwan take to change the equity?

To change equity, Abnova Taiwan can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Abnova Taiwan pay?

Over the past 12 months, Abnova Taiwan paid a dividend of 0.8 TWD . This corresponds to a dividend yield of about 2.62 %. For the coming 12 months, Abnova Taiwan is expected to pay a dividend of 0.8 TWD.

What is the dividend yield of Abnova Taiwan?

The current dividend yield of Abnova Taiwan is 2.62 %.

When does Abnova Taiwan pay dividends?

Abnova Taiwan pays a quarterly dividend. This is distributed in the months of August, July, July, July.

How secure is the dividend of Abnova Taiwan?

Abnova Taiwan paid dividends every year for the past 14 years.

What is the dividend of Abnova Taiwan?

For the upcoming 12 months, dividends amounting to 0.8 TWD are expected. This corresponds to a dividend yield of 2.62 %.

In which sector is Abnova Taiwan located?

Abnova Taiwan is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abnova Taiwan kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abnova Taiwan from 6/27/2024 amounting to 0.72 TWD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Abnova Taiwan pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Abnova Taiwan in the year 2023?

In the year 2023, Abnova Taiwan distributed 0.46 TWD as dividends.

In which currency does Abnova Taiwan pay out the dividend?

The dividends of Abnova Taiwan are distributed in TWD.